Valuation: Guizhou Bailing Group Pharmaceutical Co., Ltd.

Market Cap 627.9Cr 94Cr 84Cr 78Cr 70Cr 132.32Cr 8.95TCr 134.04Cr 934.12Cr 369.49Cr 4.68TCr 353.72Cr 346.22Cr 15TCr P/E 2024
193x
P/E 2025 -54.4x
Enterprise Value 715.37Cr 107.4Cr 96Cr 88Cr 80Cr 150.75Cr 10TCr 152.71Cr 1.06TCr 420.95Cr 5.33TCr 402.99Cr 394.45Cr 17TCr EV / Sales 2024
1.74x
EV / Sales 2025 2.23x
Free-Float
66.81%
Yield 2024 *
-
Yield 2025 -
1 day-0.22%
1 week+1.77%
Current month-1.92%
1 month+3.60%
3 months+3.14%
6 months-7.63%
Current year+5.75%
1 week 4.48
Extreme 4.48
4.64
1 month 4.48
Extreme 4.48
4.77
Current year 4.08
Extreme 4.08
5.47
1 year 4.08
Extreme 4.08
6.25
3 years 2.98
Extreme 2.98
8.8
5 years 2.98
Extreme 2.98
11.97
10 years 2.98
Extreme 2.98
23.3
Manager TitleAgeSince
Chief Executive Officer 56 02/04/2015
Director of Finance/CFO 41 29/12/2020
Corporate Officer/Principal 42 27/01/2014
Director TitleAgeSince
Chairman 56 27/03/2026
Director/Board Member 58 25/12/2007
Director/Board Member 42 27/01/2014
Date Insider Type Main position Quantity % Market Cap. Importance
21/09/20 Sell

Chairman

19,40,600 0.2495%
18/09/20 Sell

Director

36,70,000 0.4719%
18/09/20 Sell

Chairman

2,96,500 0.0381%
Change 5-day change 1-year change 3-year change Capi.($)
-0.22%+1.77%-22.03%-40.03% 94Cr
-2.54%+1.31%+55.10%+120.84% 1,13500Cr
-1.42%+3.23%+37.07%+74.26% 64TCr
+0.16%+0.08%+25.14%+97.36% 50TCr
-0.31%+3.09%+43.92%+64.55% 38TCr
-1.34%-0.47%+66.63%+40.56% 36TCr
-0.68%+2.65%+22.46%+51.48% 29TCr
-1.20%+3.04%+2.62%+26.97% 27TCr
-1.79%+1.57%+49.97%+60.87% 24TCr
-0.73%-0.10%+29.24%+101.19% 19TCr
Average -1.01%+2.08%+31.01%+59.80% 40.05TCr
Weighted average by Cap. -1.35%+2.66%+40.98%+82.10%

Financials

2024 2025
Net sales 382.54Cr 57Cr 51Cr 47Cr 43Cr 81Cr 5.45TCr 82Cr 569.1Cr 225.1Cr 2.85TCr 215.49Cr 210.93Cr 9.01TCr 304.86Cr 46Cr 41Cr 38Cr 34Cr 64Cr 4.35TCr 65Cr 453.54Cr 179.39Cr 2.27TCr 171.74Cr 168.1Cr 7.18TCr
Net income 3.36Cr 50.48L 44.97L 41.54L 37.67L 70.85L 48Cr 71.77L 5Cr 1.98Cr 25Cr 1.89Cr 1.85Cr 79Cr -10Cr -1.57Cr -1.4Cr -1.29Cr -1.17Cr -2.2Cr -148.76Cr -2.23Cr -16Cr -6.14Cr -78Cr -5.88Cr -5.75Cr -245.71Cr
Net Debt 140.03Cr 21Cr 19Cr 17Cr 16Cr 30Cr 2TCr 30Cr 208.32Cr 82Cr 1.04TCr 79Cr 77Cr 3.3TCr 87Cr 13Cr 12Cr 11Cr 9.8Cr 18Cr 1.25TCr 19Cr 130.12Cr 51Cr 651.27Cr 49Cr 48Cr 2.06TCr
Projected Income Statement - Annual - Guizhou Bailing Group Pharmaceutical Co., Ltd.
Logo Guizhou Bailing Group Pharmaceutical Co., Ltd.
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Miao medicine. The Company operates four segments. The Industrial segment is mainly engaged in the research and development, production and sales of Chinese patent medicine tablets, capsules and syrups. The Commercial segment is mainly engaged in drug distribution and big health business. The Medical Institution segment mainly operates diabetes hospitals. Other segment mainly provides Chinese medicinal materials and are engaged in organic fertilizer manufacturing, water production and supply and other businesses. The Company's products include Yindan Xinnaotong soft capsules, Kesuting syrup and capsules, Shuangyang Houbitong granules and non-Miao medicine products Jingan capsules, Vitamin C Yinqiao tablets, Xiaoer Chaigui antipyretic granules and other products. The Company mainly conducts its businesses in the domestic market.
Employees
5,715
Date Price Change Volume
23/26/23 CN¥4.600 -0.22% 76,87,600
22/26/22 CN¥4.610 +0.22% 52,56,800
21/26/21 CN¥4.600 +1.55% 59,78,203
20/26/20 CN¥4.530 -0.22% 34,08,420
19/26/19 CN¥4.540 +0.44% 47,18,800

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Guizhou Bailing Group Pharmaceutical Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 002424 Stock